1. Home
  2. PODD vs INVH Comparison

PODD vs INVH Comparison

Compare PODD & INVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • INVH
  • Stock Information
  • Founded
  • PODD 2000
  • INVH 2012
  • Country
  • PODD United States
  • INVH United States
  • Employees
  • PODD N/A
  • INVH N/A
  • Industry
  • PODD Medical/Dental Instruments
  • INVH Real Estate
  • Sector
  • PODD Health Care
  • INVH Finance
  • Exchange
  • PODD Nasdaq
  • INVH Nasdaq
  • Market Cap
  • PODD 21.5B
  • INVH 21.1B
  • IPO Year
  • PODD 2007
  • INVH 2017
  • Fundamental
  • Price
  • PODD $278.58
  • INVH $30.36
  • Analyst Decision
  • PODD Strong Buy
  • INVH Buy
  • Analyst Count
  • PODD 19
  • INVH 17
  • Target Price
  • PODD $320.11
  • INVH $38.15
  • AVG Volume (30 Days)
  • PODD 504.7K
  • INVH 3.6M
  • Earning Date
  • PODD 08-07-2025
  • INVH 07-30-2025
  • Dividend Yield
  • PODD N/A
  • INVH 3.81%
  • EPS Growth
  • PODD 67.46
  • INVH 14.19
  • EPS
  • PODD 5.55
  • INVH 0.89
  • Revenue
  • PODD $2,198,900,000.00
  • INVH $2,647,487,000.00
  • Revenue This Year
  • PODD $24.54
  • INVH $5.39
  • Revenue Next Year
  • PODD $17.48
  • INVH $3.70
  • P/E Ratio
  • PODD $50.63
  • INVH $34.30
  • Revenue Growth
  • PODD 23.48
  • INVH 5.09
  • 52 Week Low
  • PODD $173.00
  • INVH $29.37
  • 52 Week High
  • PODD $329.33
  • INVH $37.80
  • Technical
  • Relative Strength Index (RSI)
  • PODD 38.53
  • INVH 33.08
  • Support Level
  • PODD $282.75
  • INVH $29.86
  • Resistance Level
  • PODD $290.25
  • INVH $32.05
  • Average True Range (ATR)
  • PODD 5.49
  • INVH 0.62
  • MACD
  • PODD 0.05
  • INVH -0.16
  • Stochastic Oscillator
  • PODD 2.88
  • INVH 21.14

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.

About INVH Invitation Homes Inc.

Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 16 target markets that feature high employment and household formation growth with almost 70% of the portfolio in the Western U.S. and Florida; 15 of the 16 markets featuring average rents lower than homeownership costs.

Share on Social Networks: